Articles From: NICE Actimize Engages Former SEC Chairman Mary L. Schapiro and FBI Special Agent Gregory A. Coleman to Keynote 11th Annual Global Client Forum to Partner Communications Announces the Allocation of Options and Restricted Shares to the Company's Employees


An information-packed, two-day agenda addresses financial crime and compliance challenges facing global financial institutions NEW YORK , September 8, 2014 /PRNewswire/ -- NICE Actimize, a NICE Systems (NASDAQ:NICE) business and the largest and broadest provider of a single financial crime, risk and compliance software platform for the financial services industry, announces that Mary L.
Sign-up for NICE Actimize Engages Former SEC Chairman Mary L. Schapiro and FBI Special Agent Gregory A. Coleman to Keynote 11th Annual Global Client Forum investment picks
SAN FRANCISCO , Sept.
Sign-up for Nippon Prologis REIT Prices New Investment Units investment picks
Novatel Wireless, Inc. (NASDAQ: NVTL, the “Company”), a leading provider of Internet of Things, today announced that it has completed a transaction with HC2 Holdings 2, Inc. (“HC2”), a wholly owned subsidiary of HC2 Holdings, Inc. (HCHC), for a strategic investment in the Company.
Sign-up for Novatel Wireless Announces Strategic Investment from HC2 investment picks
BETHESDA, Md., Sept.
Sign-up for NOW & NEXT: Marriott International Charts Future Success investment picks
The Domain Name System (DNS) is critical network infrastructure; without DNS the Internet can’t function.
Sign-up for Now Is the Time for Secure DNS: Infoblox Enhances Its Advanced DNS Protection Solution to Block the Widest Range of DNS Attacks investment picks
2014/9/8
CARLSBAD, Calif.
Sign-up for NTN Buzztime, Inc. Announces Management Changes investment picks
NTT America , the wholly owned U.S. subsidiary of NTT Communications Corporation (NTT Com), the information and communications technology (ICT) solutions business within NTT (NYSE:NTT), today announced that its Global Solutions (GS) and Data Center Services (DCS) Business Unit will officially launch the NTT America Global Solutions Channel Partner Program at Cloud Partners 2014.
Sign-up for NTT America Builds on Strengths with New Channel Partner Program investment picks
http://media.marketwire.com/attachments/201302/125526_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142811&ProfileId=051205&sourceType=1 SAN DIEGO, CA --
Sign-up for NuVasive Spine Foundation(TM) Exceeds $13 Million in Global Effort to Support Patients in Need investment picks
2014/9/8
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced the addition of several closed-end funds to the Nuveen platform.
Sign-up for Nuveen Announces Additions to Closed-End Fund Product Line investment picks
Nuvo Research® settles litigation with Mallinckrodt Pharmaceuticals Canada NewsWire MISSISSAUGA, ON , Sept.
Sign-up for Nuvo Research® settles litigation with Mallinckrodt Pharmaceuticals investment picks
MISSISSAUGA, ON , Sept.
Sign-up for Nuvo Research® settles litigation with Mallinckrodt Pharmaceuticals investment picks
2014/9/8
EINDHOVEN, Netherlands, Sept.
Sign-up for NXP Semiconductors to Host Analyst Day investment picks
Virtual Piggy, Inc. (OTCQB:VPIG), provider of Oink, the award-winning payment technology for teens and families, today announced that it has added Jordan Harris to its team as the company’s new Risk Officer.
Sign-up for Oink Appoints Senior Fraud Expert investment picks
2014/9/8
Limited-Edition Pasta Pass Grants Unlimited Pasta during Seven-Week Promotion ORLANDO, Fla.
Sign-up for Olive Garden Introduces First-Ever 'Never Ending Pasta Pass' investment picks
Diversifies Human Nutrition Product Offerings and Broadens Global Customer Reach Transformational Acquisition Will Add Significant Human Nutrition Size and Scale Highly Complementary Transaction Expected to be Accretive to Fiscal Year 2015 Adjusted Earnings HOUSTON , Sept.
Sign-up for Omega Protein Announces Acquisition Of Bioriginal Food & Science Corp., Expanding Depth In Human Nutrition investment picks
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna ® ( imilecleucel-T ), a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS), today disclosed that the Company has commenced development in a second indication, Neuromyelitis optica (NMO). NMO is a rare autoimmune disorder, which is designated as an Orphan disease by the U.S. Food and Drug Administration (FDA). There is currently no cure and there are no FDA approved therapies for this disease.
Sign-up for Opexa Therapeutics to Target Rare Disease Neuromyelitis Optica (NMO) as next Development Program investment picks
Ophthotech Corporation (Nasdaq:OPHT) today announced that it has achieved a $50 million enrollment milestone payment from Novartis Pharma AG as part of the ex-US licensing and commercialization agreement between the two companies focused on the treatment of wet age-related macular degeneration (AMD). This enrollment milestone payment from Novartis was triggered as a result of Ophthotech reaching the first enrollment goal under the agreement in its pivotal, multi-national Fovista ® Phase 3 clinical program and is the first of a total of $130 million in potential enrollment-based milestones under the agreement.
Sign-up for Ophthotech Corporation Achieves $50 Million Milestone under Ex-US Licensing and Commercial Agreement with Novartis for Fovista® investment picks
OPKO Health, Inc. (NYSE:OPK), reported that its licensee, TESARO, Inc. (Nasdaq:TSRO), has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of oral rolapitant, an investigational neurokinin-1 (NK-1) receptor antagonist in development for the prevention of chemotherapy-induced nausea and vomiting (CINV). This NDA is supported by data from four controlled studies covering a spectrum of patients receiving chemotherapy that commonly causes nausea and vomiting.
Sign-up for OPKO Licensee TESARO Submits New Drug Application for Rolapitant investment picks
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142992&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Completes Acquisition of MICROS Systems investment picks
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142876&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Executive Keynotes to Address Complexity, Cost, Cloud, and Transformational Technologies at Oracle OpenWorld 2014 investment picks
COSTA MESA, Calif., Sept.
Sign-up for Pacific Mercantile Bank Names Robert E. Sjogren Chief Operating Officer investment picks
Pacific Rubiales announces third quarter dividend Canada NewsWire TORONTO , Sept.
Sign-up for Pacific Rubiales announces third quarter dividend investment picks
TORONTO , Sept.
Sign-up for Pacific Rubiales announces third quarter dividend investment picks
2014/9/8
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142848&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Panther Biotechnology, Inc. Announces a 6-1 Forward Stock Split to Increase Liquidity of Their Common Stock and Intent to List on the NYSE or NASDAQ investment picks
2014/9/8
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142770&ProfileId=051205&sourceType=1 DALLAS, TX --
Sign-up for Paradigm Oil & Gas Continues Growth, Adds Investor Relations Team investment picks
Partner Communications Company Ltd.
Sign-up for Partner Communications Announces the Allocation of Options and Restricted Shares to the Company's Employees investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: NICE Actimize Engages Former SEC Chairman Mary L. Schapiro and FBI Special Agent Gregory A. Coleman to Keynote 11th Annual Global Client Forum to Partner Communications Announces the Allocation of Options and Restricted Shares to the Company's Employees
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices